The business digitisation software producer is reportedly valued at $1bn, having secured $60m in a round co-led by Salesforce Ventures and backed by Accenture and New York Life.

Sunshine Insurance co-led the recruitment software producer's series C round, which will fund the development of IfChange's candidate matching technology.

The lidar technology developer has followed a $27m series A round by adding $60m from investors including existing backers Cox Enterprises and Exelon.

Roche Venture Fund was among the existing investors that helped supply $50m for Arch Oncology, the cancer drug developer formerly known as Tioma.

The online travel booking platform has collected $44.3m in a round featuring Dunamu as well as a reported $30.7m investment from Kakao.

The CNPG-backed oncology therapy developer boosted its overall funding to $70m in a round backed by Eli Lilly and CICC Capital.

Amgen Ventures, MRL Ventures Fund and Pharmaron contributed to a round that almost doubled the total raised by the bone marrow disease drug developer since 2012.

Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering's carbon capture technology.

Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.

The communication software developer boosted its total funding to $91m in a round that included Anschutz Investment Company.